Hosted on MSN
Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet
Needham on Friday upgraded Gilead Sciences, Inc. (GILD) to ‘Buy’ from ‘Hold’ as it is confident that the company’s HIV prevention injection Lenacapavir could be a multi-billion dollar contributor to ...
The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the year, according to Rwanda Biomedical Centre (RBC). The injection, given once ...
AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...
Nigeria has received Lenacapavir, a long-acting HIV prevention injection taken twice a year. Health officials say the breakthrough could transform HIV prevention and reduce new infections across the ...
Nigeria has officially received Lenacapavir, a long-acting HIV prevention injection, marking a major milestone in the country’s fight against the epidemic. Approved by the Coordinating Minister of ...
Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat the disease’s ongoing spread throughout the country. Over 100,000 people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results